Focus: Maxwell Biomedical is a San Diego-based biotech company focused on a novel external device (MAX-SRS) delivering Spatial Resynchronization Therapy to maintain sinus rhythm in atrial fibrillation patients. Company scale, funding stage, and employee count are undisclosed.
Profile data last refreshed 3h ago · AI intelligence enriched 1mo ago
Growing — net +5 jobs in 30d
5 jobs added vs 0 removed. Steady team buildout.
Early-stage device biotech with innovative AFib positioning, but lack of hiring activity and limited public data make this a high-risk, high-reward opportunity best suited for founders or highly specialized device engineers willing to operate with incomplete information.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Maxwell Biomedical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Maxwell Biomedical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles